Dental hygiene scope of practice and HbA1c are increasingly intertwined as evidence grows linking periodontal disease with glycaemic control. For UK dental hygienists regulated by the General Dental Council (GDC), understanding what HbA1c means — and how to act on a patient's self-reported value — is essential for safe, informed care. This article explores the clinical relevance of HbA1c in a dental hygiene setting, the boundaries of professional scope, the bidirectional relationship between periodontitis and blood sugar, and how to support patients with diabetes whilst working within NHS and GDC guidelines.

What Is HbA1c and Why It Matters in Dental Care

HbA1c reflects average blood glucose over two to three months and is directly relevant to dental care because elevated levels increase periodontal disease risk, impair wound healing, and create a bidirectional relationship with active periodontitis.

HbA1c, or glycated haemoglobin, is a blood marker that reflects average blood glucose levels over the preceding two to three months. It is expressed as a percentage or in millimoles per mole (mmol/mol) and is used by clinicians to diagnose and monitor diabetes mellitus. According to NICE guideline NG28, an HbA1c of 48 mmol/mol (6.5%) or above is diagnostic of type 2 diabetes in appropriate clinical contexts, whilst levels between 42–47 mmol/mol (6.0–6.4%) indicate non-diabetic hyperglycaemia — a term used in UK practice to describe those at increased risk of developing the condition. In asymptomatic individuals, a second confirmatory test is generally required before a diagnosis is made.

It is important to note that HbA1c is not suitable for diagnosing diabetes in all circumstances. It should not be used in pregnancy, in children and young people, where type 1 diabetes is suspected, or in individuals with conditions that affect red cell turnover (such as haemolytic anaemia or haemoglobinopathies). In these situations, plasma glucose measurements are used instead.

For dental professionals, HbA1c is increasingly relevant because poorly controlled blood glucose has direct implications for oral health. Patients with elevated HbA1c levels are at significantly greater risk of periodontal disease, delayed wound healing following dental procedures, and oral infections such as candidiasis. Conversely, active periodontal disease can itself contribute to worsening glycaemic control, creating a bidirectional relationship that places the dental team in a uniquely important position.

Dental hygienists do not diagnose or interpret HbA1c results in a medical capacity. However, when a patient volunteers their HbA1c value, it is helpful to understand whether it is within their individually agreed target range — as set by their GP or diabetes team — rather than applying fixed thresholds. Glycaemic targets are individualised and vary according to treatment, age, and comorbidities. If a patient reports that their HbA1c has been persistently above their agreed target, this should be noted in the clinical record and the prescribing dentist or GP informed as appropriate.

Awareness of HbA1c and its clinical context supports safer, more informed patient care and strengthens interdisciplinary communication.

Dental Hygienists' Scope of Practice in the UK

GDC-registered dental hygienists may document and use a patient's self-reported HbA1c to inform periodontal risk assessment, but are not authorised to diagnose medical conditions, prescribe, or order blood tests.

In the United Kingdom, dental hygienists are regulated by the General Dental Council (GDC) and must practise within the boundaries set out in the GDC's document Scope of Practice (2013, with updated web guidance). Dental hygienists are trained to carry out a defined range of clinical activities, including scaling and root surface debridement, oral health education, application of fluoride varnish, and taking dental radiographs under prescription. They may work to a prescription from a dentist or, under direct access arrangements introduced in 2013, see patients without a prior dental examination in certain settings.

Where dental radiographs are taken, hygienists must be aware of their responsibilities under the Ionising Radiation (Medical Exposure) Regulations 2017 (IR(ME)R). In most dental settings, hygienists act as operators — carrying out the exposure — whilst justification and authorisation of the exposure remains the responsibility of an entitled practitioner (typically a dentist). Hygienists should not act outside their IR(ME)R-defined role unless they hold the appropriate additional entitlement and training.

Importantly, dental hygienists are not authorised to diagnose medical conditions, prescribe medications, or order laboratory investigations such as HbA1c blood tests. However, they are expected to take thorough medical histories, identify risk factors relevant to oral health, and recognise when onward referral to a dentist or general practitioner (GP) is clinically appropriate. This is a critical distinction: the hygienist's role is one of identification and communication, not diagnosis.

The GDC's Standards for the Dental Team (2013) requires all registrants to:

• Recognise and work within the limits of their competence.

• Refer or seek advice when a patient's needs fall outside their scope.

• Maintain accurate, contemporaneous records of all clinical findings and actions taken, in line with FGDP(UK)/CGDent record-keeping guidance.

In the context of diabetes and HbA1c, this means a dental hygienist may note a patient's self-reported HbA1c value, document it in the clinical record, and use it to inform periodontal risk assessment — but must refer to the prescribing dentist or GP for any clinical decisions that extend beyond oral hygiene care. Working within these boundaries protects both the patient and the registrant.

The Link Between Periodontal Disease and Blood Sugar Control

Chronic periodontitis and hyperglycaemia share a bidirectional relationship; non-surgical periodontal therapy is associated with a modest mean HbA1c reduction of approximately 0.4% at three to six months in people with type 2 diabetes.

The relationship between periodontal disease and glycaemic control is one of the most well-established bidirectional associations in medicine and dentistry. Chronic periodontitis — characterised by inflammation, attachment loss, and alveolar bone destruction — is strongly associated with diabetes and is recognised as a significant comorbidity, alongside retinopathy, nephropathy, neuropathy, and macrovascular disease.

From a pathophysiological perspective, hyperglycaemia promotes the formation of advanced glycation end-products (AGEs), which impair neutrophil function, reduce collagen synthesis, and heighten the inflammatory response within periodontal tissues. This creates an environment in which periodontal pathogens such as Porphyromonas gingivalis and Tannerella forsythia thrive, accelerating tissue destruction. In turn, the systemic inflammatory burden generated by active periodontal infection — mediated by pro-inflammatory cytokines including TNF-α and IL-6 — contributes to insulin resistance, which may further elevate blood glucose levels.

Clinical evidence supports the value of periodontal treatment in improving glycaemic outcomes. A systematic review and meta-analysis (Sanz et al., 2018, Journal of Clinical Periodontology), supported by Cochrane evidence, demonstrated that non-surgical periodontal therapy was associated with a modest mean reduction in HbA1c of approximately 0.4% at three to six months in people with type 2 diabetes. Whilst this effect is clinically meaningful, it is modest, time-limited, and should be understood as complementing — not replacing — diabetes medical management. The EFP/BSP S3-level clinical practice guideline on periodontitis (2020) similarly supports the importance of periodontal care in patients with diabetes, within an integrated care framework.

Key clinical indicators that may suggest poorly controlled diabetes in a periodontal patient include:

• Rapidly progressing attachment loss disproportionate to local factors.

• Recurrent periodontal abscesses or poor response to standard treatment.

• Delayed healing following scaling or other procedures.

• Xerostomia and increased susceptibility to oral candidiasis.

Recognising these signs enables the dental hygienist to escalate concerns appropriately and contribute meaningfully to the patient's overall health management.

Referral Pathways and Working Within NHS Guidelines

When clinical signs suggest poorly controlled or undiagnosed diabetes, hygienists should document findings, inform the prescribing dentist, and advise the patient to contact their GP — calling 999 immediately if acute deterioration is present.

Effective referral is a cornerstone of safe dental hygiene practice, particularly when managing patients with diabetes or suspected undiagnosed glycaemic dysregulation. The GDC's Standards for the Dental Team (2013) is explicit that all registrants must refer promptly when a patient's needs fall outside their scope of practice. NHS England's Making Every Contact Count (MECC) framework supports brief, opportunistic conversations about general health, enabling dental professionals to signpost patients to appropriate services as part of health promotion — not as clinical advice.

1. When a dental hygienist identifies clinical features suggestive of poorly controlled or undiagnosed diabetes — such as unexplained rapid periodontal deterioration, recurrent oral infections, or a patient disclosing symptoms such as polydipsia, polyuria, or unexplained weight loss — the appropriate course of action is to:
2. Document findings clearly in the patient's clinical record.
3. Inform the prescribing dentist at the earliest opportunity, particularly if working under a dental prescription.
4. Advise the patient to consult their GP promptly if systemic symptoms are present, using clear, non-alarmist language.
5. Avoid speculating about a diagnosis or interpreting HbA1c values beyond their clinical context.

Certain presentations require more urgent action. If a patient presents with symptoms that may indicate new-onset type 1 diabetes or diabetic ketoacidosis (DKA) — such as abdominal pain, vomiting, signs of dehydration, deep or laboured breathing (Kussmaul breathing), or altered consciousness — this constitutes a potential medical emergency. In such cases, the hygienist should stop treatment, call 999 immediately, and follow the practice's medical emergency protocol. Patients reporting classic symptoms of hyperglycaemia (polydipsia, polyuria, unexplained weight loss) without acute deterioration should be advised to contact their GP the same day.

Not sure if this is normal? Chat with one of our pharmacists →

In direct access settings, where a hygienist may be the sole dental professional involved, the responsibility to refer is heightened. The GDC is explicit that direct access does not expand the clinical scope of practice — it simply removes the requirement for a prior examination. Hygienists must therefore have clear, documented protocols for escalation.

Within the MECC framework, a hygienist may appropriately signpost a patient to their GP for a diabetes review without overstepping professional boundaries, provided the conversation is framed as general health promotion rather than clinical advice.

Supporting Patients With Diabetes in a Dental Hygiene Setting

Hygienists should take an updated medical history including the patient's most recent HbA1c, tailor oral health education, confirm the patient has eaten before treatment, and know how to manage hypoglycaemia in line with Resuscitation Council UK guidance.

Dental hygienists are well placed to provide targeted, evidence-based support to patients living with diabetes, both through clinical periodontal care and structured oral health education. A patient-centred approach that acknowledges the systemic context of their oral condition can significantly improve engagement, treatment adherence, and long-term outcomes.

At the outset of care, a thorough and updated medical history is essential. Hygienists should routinely ask patients with diabetes about:

• Their most recent HbA1c value and whether it is within their individually agreed target range (as advised by their GP or diabetes team).

• Current medications, including any antidiabetic agents, as some drug classes carry oral side effects. Hygienists should check individual medicines against the relevant MHRA/EMC Summary of Product Characteristics (SmPC) for accurate adverse effect information, rather than assuming a class effect. Xerostomia is more commonly associated with anticholinergic drugs, certain antidepressants, and diuretics than with most antidiabetic agents.

• Frequency of GP or diabetic nurse reviews, to understand how actively the condition is being managed.

• Any recent changes in glycaemic control, which may affect healing and treatment planning.

Oral health education for patients with diabetes should be tailored and practical. Key messages to reinforce include the importance of twice-daily toothbrushing with fluoride toothpaste, interdental cleaning, and attending regular dental hygiene appointments. Review intervals should be determined on an individual, risk-based basis in line with NICE guideline CG19 (Dental recall: recall interval between routine dental examinations) and BSP S3-level guidance on supportive periodontal care, which recommends intervals typically ranging from three to twelve months depending on periodontal risk.

Hygienists should be mindful of patient safety during appointments. Hypoglycaemia risk is highest in patients taking insulin or sulfonylureas; metformin, SGLT-2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists carry low intrinsic hypoglycaemia risk unless used in combination with insulin or a sulfonylurea. It is good practice to:

• Confirm the patient has eaten before commencing treatment.

• Be aware of hypoglycaemia symptoms: trembling, sweating, pallor, confusion, or unusual behaviour.

• Manage hypoglycaemia in a conscious patient by giving 15–20 g of fast-acting carbohydrate (e.g., glucose tablets, a small glass of fruit juice, or a sugary drink), repeating after 15 minutes if symptoms persist, in line with Resuscitation Council UK guidance for medical emergencies in dental practice.

• Call 999 immediately if the patient loses consciousness or deteriorates rapidly, and follow the practice's medical emergency protocol.

• Document any hypoglycaemic episode in the clinical record and advise the patient to inform their GP, particularly if episodes are recurrent.

If a patient or carer reports a suspected adverse drug reaction to any medication, they should be encouraged to report this via the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk), which supports ongoing medicines safety monitoring in the UK.

By combining clinical expertise with compassionate, informed communication, dental hygienists can play a meaningful role in supporting the overall health and wellbeing of patients with diabetes — firmly within their professional scope, and in close collaboration with the wider healthcare team.

Frequently Asked Questions